Skip to main content
OpenTrials

Clinical trial condition

Malformations of Cortical Development, Group I

Explore clinical trials studying Malformations of Cortical Development, Group I. Study availability and eligibility vary by location and protocol.

123 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Malformations of Cortical Development, Group I trial results

Completed

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

NCT05864846

Conditions
Behavior, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Florida Health - Department of Neurology Gainesville, Florida, United States
  • Nicklaus Children's Health, Miami Miami, Florida, United States
View all 19 locations
View Trial Details
Completed

Zika Virus Infection's Pregnancy Consequences in French Department of America

NCT02916732

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, +8 more
Locations
  • CH Andrée Rosemon (CHAR) Cayenne, French Guiana
  • CH de l'Ouest Guyanais Franck Joly (CHOG) Saint-Laurent-du-Maroni, French Guiana
  • CHU de Pointe à Pitre/Les Abymes Pointe-à-Pitre, Guadeloupe
  • CHU de Martinique Fort-de-France, Martinique
View Trial Details
Completed

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

NCT05626634

Conditions
Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +23 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Northwest Florida Clinical Research Group Gulf Breeze, Florida, United States
View all 28 locations
View Trial Details
Completed

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

NCT05323734

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations
  • Arkansas Children's Research Institute Little Rock, Arkansas, United States
  • UCLA Mattel Children's Hospital, TSC Center Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California, San Diego San Diego, California, United States
View all 63 locations
View Trial Details
Completed

Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

NCT05059327

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
Locations
  • David Geffen School of Medicine at UCLA (Site #: 101) Los Angeles, California, United States
  • Kennedy Krieger Institute (Site #: 110) Baltimore, Maryland, United States
  • Boston Children's Hospital (Site #: 102) Boston, Massachusetts, United States
  • William Beaumont Hospital - Royal Oak (Site #: 104) Royal Oak, Michigan, United States
View all 27 locations
View Trial Details

Related conditions